Table 4 Univariate and multivariate competing risk regression for predicting 90-day mortality in male patients with HBV-ACLF.
From: Association of myosteatosis with short-term outcomes in patients with acute-on-chronic liver failure
Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age | 1.024 (0.999–1.049) | 0.061 | ||
Overweight | 0.629 (0.345–1.144) | 0.129 | ||
Liver cirrhosis | 0.978 (0.540–1.770) | 0.940 | ||
Ascites | 4.307 (1.737–10.678) | 0.002 | 1.327 (0.449–3.920) | 0.608 |
AKI | 3.766 (1.850–7.667) | < 0.001 | 1.127 (0.452–2.809) | 0.797 |
Infection | 2.406 (1.107–5.231) | 0.027 | ||
AARC score | 1.613 (1.363–1.909) | < 0.001 | 1.583 (1.308–1.916) | < 0.001 |
Sarcopenia | 3.027 (1.806–5.076) | < 0.001 | 2.025 (1.061–3.862) | 0.025 |
Visceral obesity | 0.528 (0.317–0.878) | 0.014 | ||
Myosteatosis | 2.832 (1.653–4.854) | < 0.001 | 2.119 (1.101–4.078) | 0.025 |
Sarcopenic obesity | 2.122 (1.032–4.364) | 0.041 | ||
